Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
AIDS Care
|
April 11, 2017
HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study
Carlos Roncero, Daniel Fuster, Raul Felipe Palma-Álvarez, et al.
Frontiers in Pharmacology
|
March 8, 2021
Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study
Arantza Sanvisens, Anna Hernández-Rubio, Paola Zuluaga, et al.
The Open AIDS Journal
|
March 11, 2009
Liver enzyme alterations in HCV-monoinfected and HCV/HIV-coinfected patients
Klaus Langohr, Arantza Sanvisens, Daniel Fuster, et al.
Addiction (Abingdon, England)
|
October 12, 2013
Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems
Daniel Fuster, Debbie M Cheng, Emily K Quinn, et al.
Nutrients
|
April 27, 2024
Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder
Paola Zuluaga, Julia Casado-Carbajo, Anna Hernández-Rubio, et al.
Clinical and Experimental Medicine
|
January 5, 2025
Changes in CD4<sup>+</sup> T cells subsets in patients with alcohol-related cirrhosis
Paola Zuluaga, Coral Zurera-Egea, Daniel Fuster, et al.
Journal of Clinical Medicine
|
January 21, 2022
Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change
Paola Zuluaga, Aina Teniente-Serra, Daniel Fuster, et al.
Journal of General Internal Medicine
|
January 30, 2026
Diastolic Dysfunction is Associated with Liver Fibrosis and Insulin Resistance in Alcohol Use Disorder
Anna Hernández-Rubio, Sara Ceballos, Xavier García-Calvo, et al.
BMJ Open
|
March 15, 2022
Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial
Simeon Schietzel, Lia Bally, Grazia Cereghetti, et al.
Alcoholism, Clinical and Experimental Research
|
January 17, 2013
Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders
Inmaculada Rivas, Arantza Sanvisens, Ferran Bolao, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
AIDS Care
|
April 11, 2017
HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study
Carlos Roncero, Daniel Fuster, Raul Felipe Palma-Álvarez, et al.
Frontiers in Pharmacology
|
March 8, 2021
Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study
Arantza Sanvisens, Anna Hernández-Rubio, Paola Zuluaga, et al.
The Open AIDS Journal
|
March 11, 2009
Liver enzyme alterations in HCV-monoinfected and HCV/HIV-coinfected patients
Klaus Langohr, Arantza Sanvisens, Daniel Fuster, et al.
Addiction (Abingdon, England)
|
October 12, 2013
Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems
Daniel Fuster, Debbie M Cheng, Emily K Quinn, et al.
Nutrients
|
April 27, 2024
Vitamin D Deficiency Is Associated with Advanced Liver Fibrosis and Impaired Fasting Glucose in Alcohol Use Disorder
Paola Zuluaga, Julia Casado-Carbajo, Anna Hernández-Rubio, et al.
Clinical and Experimental Medicine
|
January 5, 2025
Changes in CD4<sup>+</sup> T cells subsets in patients with alcohol-related cirrhosis
Paola Zuluaga, Coral Zurera-Egea, Daniel Fuster, et al.
Journal of Clinical Medicine
|
January 21, 2022
Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change
Paola Zuluaga, Aina Teniente-Serra, Daniel Fuster, et al.
Journal of General Internal Medicine
|
January 30, 2026
Diastolic Dysfunction is Associated with Liver Fibrosis and Insulin Resistance in Alcohol Use Disorder
Anna Hernández-Rubio, Sara Ceballos, Xavier García-Calvo, et al.
BMJ Open
|
March 15, 2022
Impact of the SGLT2 inhibitor empagliflozin on urinary supersaturations in kidney stone formers (SWEETSTONE trial): protocol for a randomised, double-blind, placebo-controlled cross-over trial
Simeon Schietzel, Lia Bally, Grazia Cereghetti, et al.
Alcoholism, Clinical and Experimental Research
|
January 17, 2013
Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders
Inmaculada Rivas, Arantza Sanvisens, Ferran Bolao, et al.
Page
of 10